Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sotiria Dimou-Besikli"'
Autor:
Eleni Gavriilaki, Emmanuel Nikolousis, Eudoxia-Evaggelia Koravou, Sotiria Dimou-Besikli, Charalampos Kartsios, Anna Papakonstantinou, Anastasia Mpanti, Charalampos Pontikoglou, Christina Kalpadaki, Aikaterini Bitsani, Ilianna Tassi, Tasoula Touloumenidou, Thomas Chatziconstantinou, Maria Papathanasiou, Antonia Syrigou, Eleutheria Ztriva, Georgia Kaiafa, Evdokia Mandala, Zois Mellios, Dimitrios Karakasis, Alexandra Kourakli, Argiris Symeonidis, Eleni Kapsali, Helen H. Papadaki, Chrysavgi Lalayanni, Ioanna Sakellari
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Given the limited real-world data of caplacizumab, our multicenter real-world study was designed to assess the safety and efficacy of caplacizumab in immune thrombotic thrombocytopenic pupura (iTTP), compared to historic controls. We have studied 70
Externí odkaz:
https://doaj.org/article/0e47eee9cc9b45b8b1af651681d65d33
Autor:
Georgios Tsakaldimis, Zoi Bousiou, Sotiria Dimou‐Besikli, Nikolaos Karakasis, Apostolos Papalakis, Stilianos Giannakopoulos, Ioanna Sakellari, Christos Kalaitzis
Publikováno v:
Clinical Case Reports, Vol 10, Iss 2, Pp n/a-n/a (2022)
Abstract The extravesical spread of gas into the extraperitoneal space is an unusual complication of emphysematous cystitis and rarely, can reach remote areas of the body. Herein, we present the case of an immunosuppressed woman with emphysematous cy
Externí odkaz:
https://doaj.org/article/36c6d8d5b9514787b68a2a814a6ed8d4
Autor:
Asimina Fylaktou, Sotiria Dimou-Besikli, Eleni Gavriilaki, Militsa Bitzani, Maria Triantafyllidou, Polychronis Tasioudis, Afroditi K. Boutou, Anastasia Papadopoulou, Penelope-Georgia Papayanni, Achilles Anagnostopoulos, Anastasia Iatrou, Georgios Karavalakis, Dimitrios Chasiotis, Diamantis Chloros, Ioannis Kioumis, Kiriakos Koukoulias, Eleni Geka, Chrysavgi Giannaki, Aphrodite Georgakopoulou, Eleni Siotou, Evangelia Yannaki
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses an urgent need for the development of effective therapies for coronavirus disease 2019 (COVID-19). Methods We first tested SARS-CoV-2–specific T-cell (CοV-2